Trial Profile
Antithymocyte Globulin (ATG) and Pegylated Granulocyte Colony Stimulating Factor (GCSF) in New Onset Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary) ; Pegfilgrastim
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- 28 Feb 2020 Status changed from active, no longer recruiting to completed.
- 08 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 17 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrails.gov record.